Form D · Private Equity Fund

PFM Healthcare Growth Equity Fund I, LP

San Francisco, CA · CIK 0001874983

Offering snapshot reported Jul 22, 2022 · SEC filing

Reported sold
$94.9M
Indefinite offering
Investors reported
46
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 12, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$47.5M$94.9MJul 26, 2021: $66,500,000.00Jul 26, 2021Jul 22, 2022: $94,925,000.00Jul 22, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$66,500,000 → $94,925,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 22, 2022Amendment$94,925,000$28,425,000vs Jul 26, 202146SEC filing
Jul 26, 2021Initial$66,500,000No comparisonNot reportedSEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-407784

Source: Form D, filed Jul 22, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

PFM HEALTHCARE GROWTH EQUITY FUND I, LP

Investment adviser: PFM HEALTH SCIENCES, LP

Gross asset value
$39.7M
Beneficial owners
46
ADV minimum commitment
$5M

Reported in Form ADV on Mar 31, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV CORP NEW YORK, New York, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor KPMG LLP SAN FRANCISCO, California, United States
Custodian GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States Related to adviser: No
Custodian JPMORGAN CHASE BANK, N.A. NEW YORK, New York, United States Related to adviser: No
Prime broker GOLDMAN SACHS & CO. LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

KPMG LLP
PCAOB 185

GOLDMAN SACHS & CO. LLC
SEC 8-129

JPMORGAN CHASE BANK, N.A.
LEI 7H6GLXDRUGQFU57RNE97

GOLDMAN SACHS & CO. LLC
CRD 361 · SEC 8-129

Filing source

Form ADV 2067094 · Mar 31, 2026 · Schedule D 7.B.(1), fund 805-3145893157

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Yuan Dubord Executive
Brian Grossman Executive
N/A Pfm Health Sciences, Lp Promoter
Darin Sadow Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Pfm Health Sciences, Lp 475 Sansome Street, Suite 1720
San Francisco, CA, 94111